Terramycin 200® for shrimp is an aquaculture premix containing oxytetracycline dehydrate (OTC) and is available through Syndel USA. OTC medicated feed can be purchased from aquaculture feed mills. OTC medicated feed can be used for the control of mortality caused by bacterial diseases in marine penaeid shrimp (primarily species of the genera Litopeneaus, Farfantepenaeus, and Penaeus). The primary goal of field studies conducted under INAD #8069 is to generate additional OTC-medicated feed efficacy data which can be used to expand existing OTC label claims. The allowed treatment dose is 4.5 gram (g) oxytetracycline per kilogram (kg) of feed for 14 consecutive days. The Investigational withdrawal period for treated shrimp is 2 days. To participate in the INAD Program for OTC medicated feed visit the data collecting site.
Please read the Study Protocol prior to any treatments. It contains the protocol, MSDS, and a copy of the forms to be used as a guide for collecting data that will be entered into the online INAD database. The FDA authorization letter(s) for this INAD is currently only available by emailing Bonnie Johnson.
INAD objective/purpose: Collect scientific data necessary to support pivotal efficacy trials to further establish the effectiveness of oxytetracycline (OTC) to control bacterial diseases of marine penaeid shrimp species that occur under a variety of environmental conditions and over a range of temperatures.
Oxytetracycline dihydrate (Terramycin 200® for Fish; TM200)
1441 W Smith Rd,
Ferndale, WA 98248 USA
Target pathogen(s): Bacterial shrimp pathogens susceptible to oxytetracycline.
Method of administration: Medicated feed treatment
Investigational Withdrawal period:
Required test parameters:
Limitations or restrictions on use of drug:
Required INAD fee: $700/facility/year
AADAP Contact Information:
Ms. Bonnie Johnson, FWS-AADAP